BioPharmX Corp. (NYSE: BPMX) Starts Presentation at 29th Annual ROTH Conference
BioPharmX (NYSE: BPMX) is a Silicon Valley-based specialty pharmaceutical company that seeks to provide products through proprietary platform technologies for prescription, over-the-counter and supplement applications in dermatology, aesthetics and women's health. The company’s product pipeline includes Violet®, the company’s initial direct-to-consumer product; BPX-01, currently in phase 2 of clinical development; and BPX-03, currently in phase 3 with regulatory filings in progress. For more information, visit the company’s website at www.BioPharmX.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an…







